Skip to main content
KLRS
NASDAQ Life Sciences

Kalaris Posts $11.5M Q2 Loss, Cash Runway Into Q4 2027; Phase 1b/2 Data Due 1H 2027

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$4.27
Mkt Cap
$86M
52W Low
$2.14
52W High
$11.88
52W Position info
100% above low
Off High info
64% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

KLRS sits 100% above its 52-week low of $2.14 on light trading volume (0.2× avg).

Summary

Kalaris reported Q2 2026 financials with a net loss of $11.5 million, nearly flat year-over-year, narrowing on lower administrative costs. Cash stands at $93.5 million, down from $118 million at year-end 2025, but management expects it to fund operations into Q4 2027 — past key clinical milestones. The Phase 1b/2 study of TH103 in wet AMD is now dosing patients, with preliminary data expected in the first half of 2027. Potential Phase 3 trials remain on track for initiation by year-end 2027. This follows the July 17 expanded Phase 1a data release that showed durable vision improvements and a clean safety profile. The cash runway extension and clinical timeline updates provide clarity on the path forward, though the company remains pre-revenue with ongoing cash burn.

At the time of this announcement, KLRS was trading at $4.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $86M. The 52-week trading range was $2.14 to $11.88. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

KLRS - Latest Insights

KLRS
Nov 10, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.85
Real-time Price: $1.90 info
Change: +$0.050 (+3%) info
Market Cap: $41.496M info
KLRS
Nov 10, 2026, 7:30 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.90 info
Change: -$0.4042 (-18%) info
Market Cap: $41.496M info
KLRS
Jul 17, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.66
Real-time Price: $1.90 info
Change: -$2.76 (-59%) info
Market Cap: $41.496M info
KLRS
Jul 17, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.58
Real-time Price: $1.90 info
Change: -$2.68 (-59%) info
Market Cap: $41.496M info
KLRS
Jun 23, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.40
Real-time Price: $1.90 info
Change: -$2.50 (-57%) info
Market Cap: $41.496M info